167 related articles for article (PubMed ID: 22119351)
1. Incidence and survival of rare urogenital cancers in Europe.
Visser O; Adolfsson J; Rossi S; Verne J; Gatta G; Maffezzini M; Franks KN;
Eur J Cancer; 2012 Mar; 48(4):456-64. PubMed ID: 22119351
[TBL] [Abstract][Full Text] [Related]
2. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
3. Rare cancers of the head and neck area in Europe.
Van Dijk BA; Gatta G; Capocaccia R; Pierannunzio D; Strojan P; Licitra L;
Eur J Cancer; 2012 Apr; 48(6):783-96. PubMed ID: 22051735
[TBL] [Abstract][Full Text] [Related]
4. Descriptive epidemiology of malignant mucosal and uveal melanomas and adnexal skin carcinomas in Europe.
Mallone S; De Vries E; Guzzo M; Midena E; Verne J; Coebergh JW; Marcos-Gragera R; Ardanaz E; Martinez R; Chirlaque MD; Navarro C; Virgili G;
Eur J Cancer; 2012 May; 48(8):1167-75. PubMed ID: 22119735
[TBL] [Abstract][Full Text] [Related]
5. Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet-a population-based study.
Gatta G; Capocaccia R; Botta L; Mallone S; De Angelis R; Ardanaz E; Comber H; Dimitrova N; Leinonen MK; Siesling S; van der Zwan JM; Van Eycken L; Visser O; Žakelj MP; Anderson LA; Bella F; Kaire I; Otter R; Stiller CA; Trama A;
Lancet Oncol; 2017 Aug; 18(8):1022-1039. PubMed ID: 28687376
[TBL] [Abstract][Full Text] [Related]
6. Carcinoma of endocrine organs: results of the RARECARE project.
van der Zwan JM; Mallone S; van Dijk B; Bielska-Lasota M; Otter R; Foschi R; Baudin E; Links TP;
Eur J Cancer; 2012 Sep; 48(13):1923-31. PubMed ID: 22361014
[TBL] [Abstract][Full Text] [Related]
7. A review of genitourinary cancers at the Korle-Bu teaching hospital Accra, Ghana.
Klufio GO
West Afr J Med; 2004; 23(2):131-4. PubMed ID: 15287291
[TBL] [Abstract][Full Text] [Related]
8. Rare cancers are not so rare: the rare cancer burden in Europe.
Gatta G; van der Zwan JM; Casali PG; Siesling S; Dei Tos AP; Kunkler I; Otter R; Licitra L; Mallone S; Tavilla A; Trama A; Capocaccia R;
Eur J Cancer; 2011 Nov; 47(17):2493-511. PubMed ID: 22033323
[TBL] [Abstract][Full Text] [Related]
9. Methodological aspects of estimating rare cancer prevalence in Europe: the experience of the RARECARE project.
Mallone S; De Angelis R; van der Zwan JM; Trama A; Siesling S; Gatta G; Capocaccia R;
Cancer Epidemiol; 2013 Dec; 37(6):850-6. PubMed ID: 24050903
[TBL] [Abstract][Full Text] [Related]
10. Incidence, survival and prevalence of myeloid malignancies in Europe.
Visser O; Trama A; Maynadié M; Stiller C; Marcos-Gragera R; De Angelis R; Mallone S; Tereanu C; Allemani C; Ricardi U; Schouten HC;
Eur J Cancer; 2012 Nov; 48(17):3257-66. PubMed ID: 22770878
[TBL] [Abstract][Full Text] [Related]
11. Burden of testicular, paratesticular and extragonadal germ cell tumours in Europe.
Trama A; Mallone S; Nicolai N; Necchi A; Schaapveld M; Gietema J; Znaor A; Ardanaz E; Berrino F;
Eur J Cancer; 2012 Jan; 48(2):159-69. PubMed ID: 22142457
[TBL] [Abstract][Full Text] [Related]
12. Rare neuroendocrine tumours: results of the surveillance of rare cancers in Europe project.
van der Zwan JM; Trama A; Otter R; Larrañaga N; Tavilla A; Marcos-Gragera R; Dei Tos AP; Baudin E; Poston G; Links T;
Eur J Cancer; 2013 Jul; 49(11):2565-78. PubMed ID: 23541566
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of glial and non-glial brain tumours in Europe.
Crocetti E; Trama A; Stiller C; Caldarella A; Soffietti R; Jaal J; Weber DC; Ricardi U; Slowinski J; Brandes A;
Eur J Cancer; 2012 Jul; 48(10):1532-42. PubMed ID: 22227039
[TBL] [Abstract][Full Text] [Related]
14. Rare thoracic cancers, including peritoneum mesothelioma.
Siesling S; van der Zwan JM; Izarzugaza I; Jaal J; Treasure T; Foschi R; Ricardi U; Groen H; Tavilla A; Ardanaz E;
Eur J Cancer; 2012 May; 48(7):949-60. PubMed ID: 22406029
[TBL] [Abstract][Full Text] [Related]
15. Primary carcinoma of the upper urinary tract.
Lauritzen AF; Kvist E; Bredesen J; Luke M
Acta Pathol Microbiol Immunol Scand A; 1987 Jan; 95(1):7-10. PubMed ID: 3825545
[TBL] [Abstract][Full Text] [Related]
16. A population-based comparison of European and North American sinonasal cancer survival.
Unsal AA; Kılıç S; Dubal PM; Baredes S; Eloy JA;
Auris Nasus Larynx; 2018 Aug; 45(4):815-824. PubMed ID: 29056464
[TBL] [Abstract][Full Text] [Related]
17. Lung cancer epidemiology among the Bahraini population, 1998-2011.
Abulfateh NM; Hamadeh RR; Fikree M
Gulf J Oncolog; 2018 Jan; 1(26):18-22. PubMed ID: 29607817
[TBL] [Abstract][Full Text] [Related]
18. Esophageal cancer in Canada: trends according to morphology and anatomical location.
Otterstatter MC; Brierley JD; De P; Ellison LF; Macintyre M; Marrett LD; Semenciw R; Weir HK
Can J Gastroenterol; 2012 Oct; 26(10):723-7. PubMed ID: 23061066
[TBL] [Abstract][Full Text] [Related]
19. The burden of rare cancers in Italy: the surveillance of rare cancers in Italy (RITA) project.
Trama A; Mallone S; Ferretti S; Meduri F; Capocaccia R; Gatta G;
Tumori; 2012; 98(5):550-8. PubMed ID: 23235748
[TBL] [Abstract][Full Text] [Related]
20. Incidence of primary urethral carcinoma in the United States.
Swartz MA; Porter MP; Lin DW; Weiss NS
Urology; 2006 Dec; 68(6):1164-8. PubMed ID: 17141838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
